Atıf İçin Kopyala
Eroglu C., ORHAN O., Ünal D., Dogu G. G., Karaca H., Dikilitas M., ...Daha Fazla
ANNALS OF THORACIC MEDICINE, cilt.8, sa.2, ss.109-115, 2013 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
8
Sayı:
2
-
Basım Tarihi:
2013
-
Doi Numarası:
10.4103/1817-1737.109824
-
Dergi Adı:
ANNALS OF THORACIC MEDICINE
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.109-115
-
Anahtar Kelimeler:
Cisplatin, concomitant chemoradiotherapy, docetaxel, non-small cell lung cancer, CONCURRENT THORACIC RADIOTHERAPY, LEUKEMIA GROUP-B, SOUTHWEST-ONCOLOGY-GROUP, PHASE-III TRIAL, RADIATION-THERAPY, RANDOMIZED-TRIAL, STAGE IIIB, CHEMORADIATION THERAPY, PROGNOSTIC-FACTORS, COMBINATION
-
Erciyes Üniversitesi Adresli:
Evet
Özet
OBJECTIVES: To evaluate treatment results and toxicities in patients who received concomitant chemoradiotherapy (CRT) followed by consolidation with docetaxel and cisplatin in locally advanced unresectable non-small cell lung cancer (NSCLC).